The Treatment of Attention-Deficit Hyperactivity Disorder: An Annotated Bibliography and Critical Appraisal of Published Systematic Reviews and Metaanalyses

Context: The Agency for Health Care Policy and Research charged the McMaster Evidence-based Practice Center with conducting a comprehensive systematic review of the literature on the treatment of attention-deficit hyperactivity disorder (ADHD), with input from various groups of stakeholders. One strategy used to avoid duplication of work included a critical appraisal of existing systematic reviews and metaanalyses. Objective: To identify and appraise published metaanalyses and systematic reviews on the treatment of ADHD and to produce an annotated bibliography. Data Sources: Medline, Cumulative Index in Nursing and Allied Health (CINAHL), Healthstar, Psycinfo, and Embase were searched to September 1998; the Cochrane Database (1998 issue 3), selected Internet sites, and the files of investigators were also reviewed. Study Selection: Review articles described as systematic reviews or metaanalyses or including a Methods section were identified independently by 3 reviewers. Data Extraction: Two reviewers extracted, by consensus, relevant information on the name, methodological quality, ADHD-related aspects (comorbid disorders, family characteristics) of those reviews; data on the population, study setting, interventions, and outcomes evaluated by the reviews were also retrieved. Results: Thirteen reviews, published from 1982 to 1998, were included. Eight included metaanalysis and 5 a qualitative review. Non-pharmacological treatments were mentioned in 6 reviews and combination therapies in 3. One review focused on the treatment of adults. Forty-seven drugs and 20 adverse effects were mentioned. Most reviews had major methodological flaws. Conclusions: Most published systematic reviews and metaanalyses on the treatment of ADHD have limited value for guiding clinical, policy, and research decisions. A rigorous, systematic review following established methodological criteria is warranted.

[1]  L. Bero,et al.  Why review articles on the health effects of passive smoking reach different conclusions. , 1998, JAMA.

[2]  W. Pelham,et al.  Empirically supported psychosocial treatments for attention deficit hyperactivity disorder. , 1998, Journal of clinical child psychology.

[3]  G. Diamond,et al.  Current status of family-based outcome and process research. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[4]  R. Tannock,et al.  Childhood hyperactivity and psychostimulants: a review of extended treatment studies. , 1993, Journal of child and adolescent psychopharmacology.

[5]  J. Swanson,et al.  Stimulant Medications and the Treatment of Children with ADHD , 1995 .

[6]  J. Biederman,et al.  Pharmacotherapy of adult attention deficit/hyperactivity disorder: a review. , 1995, Journal of clinical psychopharmacology.

[7]  R. Brumback,et al.  The Myth of Attention Deficit- Hyperactivity Disorder: Symptoms Resulting from Multiple Causes , 1992, Journal of child neurology.

[8]  A R Jadad,et al.  Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals. , 1998, JAMA.

[9]  Myron Genel,et al.  Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents , 1998 .

[10]  J. Biederman,et al.  Pharmacotherapy of Attention Deficit Hyperactivity Disorder in Adults , 1998 .

[11]  H. Moldofsky,et al.  Sleep disturbances in children with attention-deficit/hyperactivity disorder. , 1998, Journal of the American Academy of Child and Adolescent Psychiatry.

[12]  J. Biederman,et al.  Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[13]  J. Biederman,et al.  ADHD and thyroid abnormalities: a research note. , 1995, Journal of child psychology and psychiatry, and allied disciplines.

[14]  Thomas J. H. Chen,et al.  Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour. , 1995, Pharmacogenetics.

[15]  J. Biederman,et al.  Desipramine and cutaneous reactions in pediatric outpatients. , 1988, The Journal of clinical psychiatry.

[16]  A. Jadad,et al.  Meta-analyses to evaluate analgesic interventions: a systematic qualitative review of their methodology. , 1996, Journal of clinical epidemiology.

[17]  B. Peterson,et al.  Neuroimaging in child and adolescent neuropsychiatric disorders. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[18]  K. Kavale,et al.  The Efficacy of Stimulant Drug Treatment for Hyperactivity , 1982, Journal of learning disabilities.

[19]  M. Dulcan,et al.  Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[20]  G H Guyatt,et al.  Guidelines for reading literature reviews. , 1988, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[21]  M. Shevell,et al.  Pemoline-associated hepatic failure: a critical analysis of the literature. , 1997, Pediatric neurology.

[22]  K. Kavale,et al.  Hyperactivity and Diet Treatment , 1983, Journal of learning disabilities.

[23]  R G Priest,et al.  Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders , 1995, Acta psychiatrica Scandinavica. Supplementum.

[24]  J. C. Hill,et al.  Age-dependent decline of attention deficit hyperactivity disorder. , 1996, The American journal of psychiatry.

[25]  R. Klein,et al.  Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without ADHD: a meta-analytic review. , 1996, Journal of child psychology and psychiatry, and allied disciplines.

[26]  Jesse A Berlin,et al.  Does blinding of readers affect the results of meta-analyses? , 1997, The Lancet.

[27]  K J Ottenbacher,et al.  DRUG TREATMENT OF HYPERACTIVITY IN CHILDREN , 1983, Developmental medicine and child neurology.

[28]  R. Silva,et al.  Carbamazepine use in children and adolescents with features of attention-deficit hyperactivity disorder: a meta-analysis. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[29]  G. Kewley.  Personal paper: attention deficit hyperactivity disorder is underdiagnosed and undertreated in Britain. , 1998, BMJ.

[30]  G. Guyatt,et al.  Validation of an index of the quality of review articles. , 1991, Journal of clinical epidemiology.

[31]  S Thurber,et al.  Medication and hyperactivity: a meta-analysis. , 1983, The Journal of general psychology.

[32]  Francis M. Crinella,et al.  Effect of Stimulant Medication on Children with Attention Deficit Disorder: A “Review of Reviews” , 1993 .

[33]  J. W. White,et al.  The effect of sugar on behavior or cognition in children. A meta-analysis. , 1995, JAMA.

[34]  G. Strauss,et al.  Psychiatric hospitalization of adolescents for conduct disorder. , 1994, Hospital & community psychiatry.

[35]  J. Swanson,et al.  NIMH collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.